Conformis, Inc. Provides Business Update and Initial Expectations for 2022
06 janv. 2022 07h00 HE
|
Conformis, Inc.
Company Launches Innovative Image-to-Implant® Platinum Services℠ Program to Better Serve Patients and Surgeons BILLERICA, Mass., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), an...
Conformis, Inc. to Provide Business Update and Initial Expectations for 2022 on January 6, 2022
04 janv. 2022 08h30 HE
|
Conformis, Inc.
BILLERICA, Mass., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will provide a business update and initial expectations for 2022 before the market opens on...
Conformis, Inc. Announces Departure of Chief Legal Officer, Corporate Secretary
23 déc. 2021 08h30 HE
|
Conformis, Inc.
BILLERICA, Mass., Dec. 23, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that Brent Alldredge, Chief Legal Officer and Corporate Secretary, has notified the Company that he...
Conformis, Inc. Appoints James Paiva as its new Vice President of U.S. Marketing; Inducement Grant Reported
08 nov. 2021 09h00 HE
|
Conformis, Inc.
BILLERICA, Mass., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that the Company has appointed James Paiva as its new Vice President, U.S. Marketing. “Conformis...
Conformis Reports Third Quarter 2021 Financial Results
03 nov. 2021 16h05 HE
|
Conformis, Inc.
BILLERICA, Mass., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today...
Conformis, Inc. to Release Third Quarter 2021 Financial Results on November 3, 2021
04 oct. 2021 17h00 HE
|
Conformis, Inc.
BILLERICA, Mass., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will release its financial results for the third quarter ended September 30, 2021 after the...
Conformis, Inc. Announces Strong Clinical Study Results for Its Personalized Knee Implants
29 sept. 2021 17h00 HE
|
Conformis, Inc.
BILLERICA, Mass., Sept. 29, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today the strong results of a published retrospective study of procedures using Conformis’...
Conformis, Inc. Provides Business Update
20 sept. 2021 16h30 HE
|
Conformis, Inc.
BILLERICA, Mass., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) provided today an update of its third quarter revenue performance expectations in advance of the Oppenheimer Fall...
Conformis, Inc. to Participate in Upcoming Investor Conferences
07 sept. 2021 17h00 HE
|
Conformis, Inc.
BILLERICA, Mass., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), an orthopedic medical device company that features a range of personalized knee and hip replacement products,...
Conformis, Inc. Announces First Procedure Performed Using the Identity Imprint™ Knee Replacement System
18 août 2021 17h00 HE
|
Conformis, Inc.
BILLERICA, Mass., Aug. 18, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) today announced the first procedure with the new Conformis Identity Imprint knee replacement system. Identity...